(Q46496031)

22 December 2017

title

Direct comparison of dietary portfolio vs statin on C-reactive protein (English)

1 reference

22 December 2017

author name string

Jenkins DJ

1

1 reference

22 December 2017

Kendall CW

2

1 reference

22 December 2017

Marchie A

3

1 reference

22 December 2017

Faulkner DA

4

1 reference

22 December 2017

Josse AR

5

1 reference

22 December 2017

Wong JM

6

1 reference

22 December 2017

de Souza R

7

1 reference

22 December 2017

Emam A

8

1 reference

22 December 2017

Parker TL

9

1 reference

22 December 2017

Li TJ

10

1 reference

22 December 2017

Josse RG

11

1 reference

22 December 2017

Leiter LA

12

1 reference

22 December 2017

Singer W

13

1 reference

22 December 2017

Connelly PW

14

1 reference

22 December 2017

publication date

1 July 2005

1 reference

22 December 2017

European Journal of Clinical Nutrition

published in

1 reference

22 December 2017

volume

59

1 reference

22 December 2017

issue

7

1 reference

22 December 2017

page(s)

851-860

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ejcn.1602152

exact match

0 references

cites work

Alcohol consumption and plasma concentration of C-reactive protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Effect of physical activity on serum C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Body mass index, diabetes, and C-reactive protein among U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Independent association of various smoking characteristics with markers of systemic inflammation in men. Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Effect of pravastatin in mildly hypercholesterolemic young men on serum matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Hormone replacement therapy and increased plasma concentration of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Inflammatory markers and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

C-reactive protein reassessed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJCN.1602152

Effects of fluvastatin and bezafibrate combination on plasma fibrinogen, t-plasminogen activator inhibitor and C reactive protein levels in coronary artery disease patients with mixed hyperlipidaemia (FACT study). Fluvastatin Alone and in [...]

21 January 2018

1 reference

12 December 2020

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women

1 reference

12 December 2020

Population distributions of C-reactive protein in apparently healthy men and women in the United States: implication for clinical interpretation

1 reference

12 December 2020

Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile

1 reference

12 December 2020

Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults.

1 reference

12 December 2020

International table of glycemic index and glycemic load values: 2002.

1 reference

12 December 2020

Pro- and anti-inflammatory cytokines in healthy volunteers fed various doses of fish oil for 1 year

1 reference

12 December 2020

Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project

1 reference

12 December 2020

Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants.

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.EJCN.1602152

1 reference

22 December 2017

0 references

1 reference

22 December 2017